Towa Pharmaceutical Finalizes Restricted Stock Compensation
Company Announcements

Towa Pharmaceutical Finalizes Restricted Stock Compensation

Towa Pharmaceutical Co (JP:4553) has released an update.

Towa Pharmaceutical Co., Ltd. has successfully completed the issuance of restricted stock to certain directors as part of their compensation strategy. The company allocated 8,250 shares of common stock at a price of JPY 2,880 per share, amounting to a total of JPY 23,760,000. This move, executed on July 18, 2024, is part of Towa’s commitment to aligning the interests of its directors with those of the company.

For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Japan Auto-Generated NewsdeskTowa Pharmaceutical Expands and Revises Earnings Forecast
TipRanks Japan Auto-Generated NewsdeskTowa Pharmaceutical Reports Strong Q1 2024 Growth
TipRanks Japan Auto-Generated NewsdeskTowa Pharmaceutical Raises Profit Forecasts
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App